FO

Fine Organic Industries Ltd

Q4 FY25Chemicals & Petrochemicals

Fine Organic Industries Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹5,160
Market cap₹15.1K Cr
P/E37.1
Updated23 Aug 2026
Read4 min read

The short version

Domestic demand is growing strongly at around 8-10% CAGR, higher than the global average of 5-6%. Fine Organic Industries projects growth driven by new capacities at JNPA SEZ facility (INR 700-750 crores capex over 18-24 months) and upcoming U.S.

From Fine Organic Industries Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Domestic demand is growing strongly at around 8-10% CAGR, higher than the global average of 5-6%.
  • Current plants (except Patalganga) are running near full capacity; growth would mainly come from ramping up Patalganga plant and new SEZ plant.
  • The SEZ facility (JNPTA) primarily targets exports and will free capacity at existing plants for domestic growth; expected commissioning in 18-24 months.
  • U.S. manufacturing facility planned to strengthen local market presence; initial capacity conservative but expected rapid fill due to existing customer base.
  • Overall volume growth expected to be moderate (around 5-6% CAGR) until new capacities (JNPTA, U.S.) come online.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Fine Organic Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • INR 750 crores capex planned for new manufacturing facility at JNPA SEZ, Maharashtra, to be completed in 18-24 months (Phased production start) (Pages 3-5).
  • Incorporation of a new wholly owned manufacturing entity in the U.S. underway to enhance local presence and serve U.S. customers better; initial capacity will be conservative with phase-wise expansions expected (Pages 4-7).
  • Wholly owned subsidiary being set up in UAE for better supply chain efficiency in Middle East (Page 4).
  • Capex in FY '25 was around INR 125 crores including maintenance and R&D, with some capacity creation (Pages 9-11).

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
Rev 1Mar 2
2Solar Industries
Rev 2Mar 1
3
Rev 2Mar 1
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Fine Organic Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The transcript does not explicitly mention the current or expected orderbook or pending orders for Fine Organic Industries Limited.
  • However, it is indicated that all plants, except one (E-73 Patalganga), are running almost at full capacity, suggesting strong demand.
  • The company is not losing existing business but cannot onboard big new accounts until additional capacity is available.
  • They expect some volume growth from the existing capacity ramp-up at Patalganga and new plants like JNPA and U.S. facility in the future.
  • Large customers prefer long-term contracts (12 months), indicating stable order commitments.

2 more points management made on order book & pipeline

Fine Organic Industries Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹625 Cr, net profit ₹117 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Vinati Organics Ltd (Q4 FY25)

    Overall growth supported by strategic capex (~INR360 crores in FY26), innovation, and operational efficiencies. Key concall takeaways from Vinati Organics's Q4…

  • Rossari Biotech Ltd (Q4 FY25)

    Consumer and Institutional businesses grew 67% YoY to Rs. Key concall takeaways from Rossari Biotech Ltd's Q4 FY25 earnings call — and how it ranks against…

  • Solar Industries (Q4 FY25)

    For FY '26, Solar Industries is confident of crossing INR 10,000 crores in revenue. Key concall takeaways from Solar Industries India Ltd's Q4 FY25 earnings…

  • Asahi Songwon Colors Ltd (Q4 FY25)

    AZO segment capacity utilization to improve from 64% to around 80-85%, with top line growth from ₹70 crores to ₹90 crores (~26-27% growth) (Page 16). Key…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Fine Organic Industries Ltd Q4 FY25 results?

Domestic demand is growing strongly at around 8-10% CAGR, higher than the global average of 5-6%. Fine Organic Industries projects growth driven by new capacities at JNPA SEZ facility (INR 700-750 crores capex over 18-24 months) and upcoming U.S.

What is Fine Organic Industries Ltd share price analysis?

Fine Organic Industries Ltd currently shows a neutral. The stock trades at a P/E of 37.1 with a market cap of ₹15,147 Cr. Investors should review the full earnings analysis for detailed insights.

Is Fine Organic Industries Ltd planning capital expenditure?

INR 750 crores capex planned for new manufacturing facility at JNPA SEZ, Maharashtra, to be completed in 18-24 months (Phased production start) (Pages 3-5). - Incorporation of a new wholly owned manufacturing entity in the U.S.

Keep Fine Organic Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.